1. Home
  2. NVNO vs TORO Comparison

NVNO vs TORO Comparison

Compare NVNO & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • TORO
  • Stock Information
  • Founded
  • NVNO 1987
  • TORO 2022
  • Country
  • NVNO United States
  • TORO Cyprus
  • Employees
  • NVNO N/A
  • TORO N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • TORO Marine Transportation
  • Sector
  • NVNO Health Care
  • TORO Consumer Discretionary
  • Exchange
  • NVNO Nasdaq
  • TORO Nasdaq
  • Market Cap
  • NVNO 16.7M
  • TORO 57.9M
  • IPO Year
  • NVNO N/A
  • TORO N/A
  • Fundamental
  • Price
  • NVNO $0.90
  • TORO $3.08
  • Analyst Decision
  • NVNO
  • TORO
  • Analyst Count
  • NVNO 0
  • TORO 0
  • Target Price
  • NVNO N/A
  • TORO N/A
  • AVG Volume (30 Days)
  • NVNO 2.4M
  • TORO 27.4K
  • Earning Date
  • NVNO 10-30-2025
  • TORO 11-11-2025
  • Dividend Yield
  • NVNO N/A
  • TORO N/A
  • EPS Growth
  • NVNO N/A
  • TORO N/A
  • EPS
  • NVNO N/A
  • TORO N/A
  • Revenue
  • NVNO N/A
  • TORO $21,513,733.00
  • Revenue This Year
  • NVNO N/A
  • TORO N/A
  • Revenue Next Year
  • NVNO N/A
  • TORO N/A
  • P/E Ratio
  • NVNO N/A
  • TORO N/A
  • Revenue Growth
  • NVNO N/A
  • TORO N/A
  • 52 Week Low
  • NVNO $0.67
  • TORO $1.70
  • 52 Week High
  • NVNO $5.62
  • TORO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 25.14
  • TORO 67.39
  • Support Level
  • NVNO $0.67
  • TORO $2.81
  • Resistance Level
  • NVNO $0.93
  • TORO $3.14
  • Average True Range (ATR)
  • NVNO 0.07
  • TORO 0.10
  • MACD
  • NVNO 0.13
  • TORO 0.04
  • Stochastic Oscillator
  • NVNO 85.15
  • TORO 88.00

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About TORO Toro Corp.

Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.

Share on Social Networks: